Molecular mechanism of cholangiocarcinoma carcinogenesis.
about
Deregulated MicroRNAs in Biliary Tract Cancer: Functional Targets and Potential BiomarkersRepurposing cimetidine for cholangiocarcinoma: Antitumor effects in vitro and in vivo.HOXD10 acts as a tumor-suppressive factor via inhibition of the RHOC/AKT/MAPK pathway in human cholangiocellular carcinomamiR-124 targets GATA6 to suppress cholangiocarcinoma cell invasion and metastasis.Whole-exome tumor sequencing study in biliary cancer patients with a response to MEK inhibitors.Long non-coding RNA H19 regulates FOXM1 expression by competitively binding endogenous miR-342-3p in gallbladder cancer.Halogenated hydrocarbon solvent-related cholangiocarcinoma risk: biliary excretion of glutathione conjugates of 1,2-dichloropropane evidenced by untargeted metabolomics analysis.Antischistosomiasis Liver Fibrosis Effects of Chlorogenic Acid through IL-13/miR-21/Smad7 Signaling Interactions In Vivo and In Vitro.Glasgow Prognostic Score predicts prognosis of intrahepatic cholangiocarcinomaRole of the fibroblast growth factor receptor axis in cholangiocarcinoma.Tumor Microenvironment Versus Cancer Stem Cells in Cholangiocarcinoma: Synergistic Effects?Identification of transcription factors (TFs) and targets involved in the cholangiocarcinoma (CCA) by integrated analysis.Biliary tract cancer stem cells - translational options and challenges.Crosstalk between the Notch signaling pathway and non-coding RNAs in gastrointestinal cancers.MicroRNA-26b-5p regulates cell proliferation, invasion and metastasis in human intrahepatic cholangiocarcinoma by targeting S100A7.MiR-433 and miR-22 dysregulations induce HDAC6 overexpression and ciliary loss in cholangiocarcinoma.High expression of karyopherin-α2 and stathmin 1 is associated with proliferation potency and transformation in the bile duct and gall bladder epithelia in the cases of pancreaticobiliary maljunction.Translational Bioinformatics for Cholangiocarcinoma: Opportunities and Challenges.
P2860
Q28073195-7DE39078-6087-4AF8-9B1B-24AAC39F18B9Q33598215-CEC7B898-1116-4898-8A4D-A5A10C341335Q36041680-F03C2E13-8ABF-4D65-BE5A-E507EEDF7E2FQ36300089-1E9518CF-3DE7-44A3-A31B-57806B8BC725Q36905641-4A2024E0-4989-45BC-BB76-F881E282E67DQ37307816-45EB8C0F-2530-4714-B2F6-3F156A160DEBQ37604222-F21AD5D0-992B-4AFC-8605-55E742F7DC56Q37613026-DC4F5B48-EE99-4BD9-B070-11623C5A3DA0Q37731958-9953EC60-B392-43FF-85D5-575CB751F188Q38354294-3ED0D420-0CCA-40BB-844B-B63393133898Q38584340-EE0E5285-3682-4948-8502-CE6F5F9206BBQ39179218-1C95463B-2092-46EF-8E05-341FAC00F986Q39279276-016A2536-7FC4-403B-AD0B-26976A71417EQ47101032-CF508063-0802-4E4F-AF7E-018A49AC5FDDQ49479465-09DA90CB-EA38-4B92-B9CA-AF3BF0C67C7CQ50182542-F7064A75-25BB-4015-9D5F-2094F7FC5731Q51685400-ABE7F02A-A48F-4AC1-BA62-594973CC9781Q55513254-B88D1EBB-8409-4065-89F0-7E52E8BBC96E
P2860
Molecular mechanism of cholangiocarcinoma carcinogenesis.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Molecular mechanism of cholangiocarcinoma carcinogenesis.
@en
type
label
Molecular mechanism of cholangiocarcinoma carcinogenesis.
@en
prefLabel
Molecular mechanism of cholangiocarcinoma carcinogenesis.
@en
P2093
P2860
P356
P1476
Molecular mechanism of cholangiocarcinoma carcinogenesis.
@en
P2093
Kosei Maemura
Shoji Natsugoe
Sonshin Takao
P2860
P304
P356
10.1002/JHBP.126
P577
2014-06-03T00:00:00Z